Phospholipid remodeling and its derivatives are associated with COVID-19 severity
Juntong Wei1, Xiaoyu Liu2, Weimin Xiao3
1Department of Respirology and Allergy. Third Affiliated Hospital of Shenzhen University. Shenzhen, China; State Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, China.
Insights
Phospholipid metabolism alterations, particularly specific phosphatidylcholine and lysophosphatidylcholine ratios, can predict COVID-19 severity. These phospholipid changes may play a role in disease progression and pathogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Early classification of severe COVID-19 cases is challenging, hindering timely intervention and effective mortality reduction.
- Understanding COVID-19 pathogenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate circulating phospholipid metabolite levels and their correlation with COVID-19 severity.
- To explore the potential role of phospholipids in COVID-19 disease progression.
Main Methods:
- Nontargeted lipidomic analysis of plasma samples from COVID-19 patients with varying severity, healthy individuals, and subjects with metabolic disease.
- Statistical analysis to identify correlations between phospholipid ratios and disease severity.
Main Results:
- Significant alterations in phospholipid metabolism were observed in COVID-19 patients.
- Specific phosphatidylcholine (PC)/lysophosphatidylcholine (LPC) and phosphatidylethanolamine (PE)/lysophosphatidylethanolamine (LPE) ratios correlated significantly with COVID-19 severity.
- Lower ratios of (PC16:1/22:6)/LPC 16:1 and (PE18:1/22:6)/LPE 18:1 were indicative of severe COVID-19.
- Elevated LPC 16:1 and LPE 18:1 levels contributed to altered lipid ratios and demonstrated membrane perturbation, increased intracellular calcium, cytokines, and apoptosis in cellular models.
Conclusions:
- Remodeling of phospholipid metabolism is present in severe COVID-19.
- Specific phospholipids may serve as valuable biomarkers for evaluating COVID-19 severity and understanding its pathogenesis.
Background:
Timely medical intervention in severe cases of coronavirus disease 2019 (COVID-19) and better understanding of the disease's pathogenesis are essential for reducing mortality, but early classification of severe cases and its progression is challenging.
Objective:
We investigated the levels of circulating phospholipid metabolites and their relationship with COVID-19 severity, as well as the potential role of phospholipids in disease progression.
Methods:
We performed nontargeted lipidomic analysis of plasma samples (n = 150) collected from COVID-19 patients (n = 46) with 3 levels of disease severity, healthy individuals, and subjects with metabolic disease.
Results:
Phospholipid metabolism was significantly altered in COVID-19 patients. Results of a panel of phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) and of phosphatidylethanolamine and lysophosphatidylethanolamine (LPE) ratios were significantly correlated with COVID-19 severity, in which 16 phospholipid ratios were shown to distinguish between patients with severe disease, mild disease, and healthy controls, 9 of which were at variance with those in subjects with metabolic disease. In particular, relatively lower ratios of circulating (PC16:1/22:6)/LPC 16:1 and (PE18:1/22:6)/LPE 18:1 were the most indicative of severe COVID-19. The elevation of levels of LPC 16:1 and LPE 18:1 contributed to the changes of related lipid ratios. An exploratory functional study of LPC 16:1 and LPE 18:1 demonstrated their ability in causing membrane perturbation, increased intracellular calcium, cytokines, and apoptosis in cellular models.
Conclusion:
Significant Lands cycle remodeling is present in patients with severe COVID-19, suggesting a potential utility of selective phospholipids with functional consequences in evaluating COVID-19's severity and pathogenesis.
Related Concept Videos
Asymmetric Lipid Bilayer
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Biosynthesis of Lipids
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
Membrane Fluidity


